July 18, 2012 -- “Neurological disorders affect millions of people around the world and represent a vast and growing need for new and improved treatment options,” said Michael T. Modic, MD, FACR, Cleveland Clinic’s Chief Emerging Business Officer. “There is significant opportunity to develop novel treatments and therapies for neurological disorders, such as Alzheimer’s disease, and improve patient care, which is an integral part of Cleveland Clinic’s mission.”
The alliance will provide physicians and researchers at Cleveland Clinic’s Neurological Institute (CCNI) with systems and tools to improve clinical research management by integrating academic expertise and industry best practices. Numoda’s patented technology platforms will streamline and better control increasingly complex clinical trial protocols and drug development processes for pharma, biotech, medical device and diagnostic companies. Numoda will also provide CCNI researchers with information systems, reporting engines, and administrative tools for improved results in patient recruitment, budgeting and data flow.
“This collaboration will marry advanced academic medical research center knowledge and expertise with administrative agility, allowing us to quickly develop life-enhancing and life-saving treatments,” said Mary Schaheen, CEO of Numoda Corporation. “We want to make new treatments for neurological diseases available quickly and at lower costs.”
The multidisciplinary CCNI is a leader in treating and researching the most complex neurological disorders, advancing innovations such as epilepsy surgery, stereotactic spine radiosurgery, interstitial thermal therapy for brain tumors and deep brain stimulation. Cleveland Clinic patients benefit from the latest treatment modalities at the Neurological Institute, where scientists and clinicians working together continue to advance innovations and accelerate the process of bringing novel therapeutic agents from the laboratory to the bedside.
Numoda Corporation is the world’s most innovative and complete technology solutions provider for the clinical, logistical and financial management of medical research in the life sciences industry. Numoda has made drug development a much smarter, faster and less risky process with its pioneering and patented means for integrating and presenting through a single interface the entire body of clinical research in global studies from every source (e.g., investigator sites, labs, imaging centers, ECG, interactive voice/web response systems, patient diaries, drug supply chains, etc.). Through an investment affiliate, Numoda also helps clients advance their medical research through funding and facilitating strategic partnerships. Visit Numoda Corporation at www.numoda.com.
About Cleveland Clinic
Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. About 2,000 full-time salaried physicians and researchers and 7,600 nurses at Cleveland Clinic represent more than 100 medical specialties and subspecialties. In addition to its main campus, Cleveland Clinic operates nine community hospitals in Northeast Ohio, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas and Cleveland Clinic Canada. In 2008, there were more than 4.2 million visits throughout the Cleveland Clinic health system and 165,000 hospital admissions. Patients came for treatment from every state and from more than 80 countries. Visit Cleveland Clinic at clevelandclinic.org.